Search solution supports R&D
Biopharmaceutical company AstraZeneca wanted an enterprise search platform to handle its R&D organization globally. After a competition to determine which solution would work best for the company, AstraZeneca chose Sinequa for its real-time big data search and analytics functionality.
The pharmaceutical company was impressed by a number of features including Sinequa’s semantic analysis and text mining capabilities, its tunable relevance algorithms and many out-of-the-box connectors to heterogeneous data sources, according to Sinequa.
Nick Brown, associate director, R&D information at AstraZeneca, says, “We have found a partner with Sinequa that brings a next-generation search platform and will innovate closely with us. In only a few months, we have indexed tens of millions of documents and delivered cutting-edge business applications to our users. We are excited to see what the future of big data analytics is together.”
At first AstraZeneca will use Sinequa for R&D so its scientists can find relevant information concerning drugs, diseases and genes, as well as a variety of other scientific concepts. About 200 million internal and external documents will be indexed and a variety of mobile business applications will be built on top of that content.
Xavier Pornain, VP of sales and alliances of Sinequa, says, “This is a major deal and it confirms--in our view--that there is a new market for search and analytics in the big data era, with ever more powerful use cases that have moved to the core of the business of user organizations.”
(Image courtesy of ShutterStock.com)